Literature DB >> 19768189

Molecular pathogenesis of liver fibrosis.

David A Brenner1.   

Abstract

Hepatic fibrosis is the final common pathway for most chronic liver diseases. The cell responsible for hepatic fibrosis appears to be the activated myofibroblast. The myofibroblast may be derived from quiescent hepatic stellate cells, epithelial to mesenhymal transition, or derived from bone marrow precursors. Studies in primary cultures of myofibroblasts and in mouse models of hepatic fibrosis have revealed several common pathophysiological mechanisms. Hepatic fibrosis is strongly associated with oxidative stress, increased transforming growth factor beta, hepatocyte death, and chronic inflammation. Finally, the reversal of fibrosis depends upon the elimination of the activated myofibroblast.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768189      PMCID: PMC2744540     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  5 in total

1.  Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.

Authors:  Tatiana Kisseleva; Hiroshi Uchinami; Nikki Feirt; Oscar Quintana-Bustamante; Jose Carlos Segovia; Robert F Schwabe; David A Brenner
Journal:  J Hepatol       Date:  2006-06-09       Impact factor: 25.083

2.  What is the potential role of antifibrotic agents for the treatment of liver disease?

Authors:  Bernd Schnabl; David Scholten; David A Brenner
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-07-15

Review 3.  Toll-like receptors and adaptor molecules in liver disease: update.

Authors:  Ekihiro Seki; David A Brenner
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

4.  The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo.

Authors:  C Hellerbrand; B Stefanovic; F Giordano; E R Burchardt; D A Brenner
Journal:  J Hepatol       Date:  1999-01       Impact factor: 25.083

5.  Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.

Authors:  Samuele De Minicis; Ekihiro Seki; Christoph Oesterreicher; Bernd Schnabl; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

  5 in total
  98 in total

1.  SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.

Authors:  Barbara Renga; Andrea Mencarelli; Marco Migliorati; Sabrina Cipriani; Claudio D'Amore; Eleonora Distrutti; Stefano Fiorucci
Journal:  Inflamm Res       Date:  2011-01-29       Impact factor: 4.575

2.  Thymosin-β4 (Tβ4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells.

Authors:  Karina Reyes-Gordillo; Ruchi Shah; Anastas Popratiloff; Sidney Fu; Anna Hindle; Frederick Brody; Marcos Rojkind
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.

Authors:  Ashley M Lakner; Nury M Steuerwald; Tracy L Walling; Sriparna Ghosh; Ting Li; Iain H McKillop; Mark W Russo; Herbert L Bonkovsky; Laura W Schrum
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

4.  Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems.

Authors:  Felipe T Lee-Montiel; Subin M George; Albert H Gough; Anup D Sharma; Juanfang Wu; Richard DeBiasio; Lawrence A Vernetti; D Lansing Taylor
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-14

Review 5.  The role of cirrhosis in the etiology of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  J Gastrointest Cancer       Date:  2014-03

6.  Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy.

Authors:  Hong-Min Ni; Benjamin L Woolbright; Jessica Williams; Bryan Copple; Wei Cui; James P Luyendyk; Hartmut Jaeschke; Wen-Xing Ding
Journal:  J Hepatol       Date:  2014-05-09       Impact factor: 25.083

7.  TGF-β1 signaling activates hepatic stellate cells through Notch pathway.

Authors:  Yasen Aimaiti; Maimaitinijiati Yusufukadier; Wending Li; Tusun Tuerhongjiang; Apar Shadike; Aisan Meiheriayi; Aini Abudusalamu; Hui Wang; Aji Tuerganaili; Yingmei Shao; Hao Wen
Journal:  Cytotechnology       Date:  2019-08-01       Impact factor: 2.058

8.  Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.

Authors:  Norihiko Sakai; Andrew M Tager
Journal:  Biochim Biophys Acta       Date:  2013-03-14

Review 9.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

10.  Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.

Authors:  Bo-Lin Chen; Jie Peng; Qing-Fu Li; Min Yang; Yuan Wang; Wei Chen
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.